In a regulatory filing, cannabinoid-based cosmeceutical maker Endocan (ENDO +10.3%) discloses that its original accountant Scott W. Hatfield, CPA had his registration revoked by the PCAOB as of July 11, 2013. Since then, the company has been unable to communicate with Mr. Hatfield to find out why this happened. On June 5, 2014 the firm engaged Turner, Stone & Co. as its certifying accountant who will re-audit fiscal years 2012 and 2011 in addition to 2013.
On June 27, 2013 Robert Kane resigned as President. Dr. Dorothy Brray replaced him the same day.
On May 16, 2014 Alfredo Dupetit resigned as a Director and VP of European Operations.
On April 24, 2014 the company's BOD and a majority of its shareholders voted to change its name to Omnicanna Health Solutions. The change will go into effect as soon as FINRA approves it.